Cui WH

No ORCID on file · 1 paper in corpus · active 2026

Study types

  • other 1
other 2026
Frontiers in medicine ·doi:10.3389/fmed.2026.1797331

INTRODUCTION: Mineralocorticoid receptor antagonists, spironolactone, eplerenone, and finerenone, are cornerstone therapies in cardiovascular and renal diseases. While their efficacy is established, a systematic, head-to-head comparison of …